The trajectory of companies tied to iconic drugs like Viagra presents a challenging investment picture. While the initial rise of copyright, fueled by Viagra's unprecedented popularity, generated substantial wealth , the loss of exclusivity in key markets has introduced considerable uncertainty . Investors are now grappling with the effect of gener